Master of Biomedical Science — Pharmacogenomics — study plan
- Credit hours
- 43
- Levels
- 4
- Courses
- 10
- Degree
- master
The Master of Biomedical Science — Pharmacogenomics study plan at Alfaisal University is an accredited master programme spanning about 2 years (4 academic levels), requiring 43 credit hours across 10 courses of required and elective study. The table below lists the courses and their credit hours for each level.
Semester 1 11 credits
| Code | Course | Credits |
|---|---|---|
| MBS 692 | Fundamentals of Human Genetics and Genomics | 4 |
| MBS 597 | Practicum A: Genome Sequencing | 4 |
| REC 504 | Biomedical Ethics | 3 |
Semester 2 11 credits
| Code | Course | Credits |
|---|---|---|
| REC 503 | Research Methodologies | 3 |
| MBS 697 | Translational Medicine | 3 |
| MBS 693 | Clinical Pharmacology/Pharmacogenomics | 2 |
| MBS 691 | Introduction to Pharmacogenomics | 3 |
Semester 3 12 credits
| Code | Course | Credits |
|---|---|---|
| MBS 600 | Thesis A | 9 |
| REC 502 | Biostatistics | 3 |
Semester 4 9 credits
| Code | Course | Credits |
|---|---|---|
| MBS 600 | Thesis B | 9 |
This plan is transcribed from the university's official source. Always confirm the plan approved for your own cohort before registering. Official source
Calculate your GPA for this major
Frequently asked questions about Master of Biomedical Science — Pharmacogenomics
How many credit hours is Master of Biomedical Science — Pharmacogenomics at Alfaisal University?
Master of Biomedical Science — Pharmacogenomics at Alfaisal University requires completing 43 credit hours to graduate, spread across 10 courses.
How many years is Master of Biomedical Science — Pharmacogenomics at Alfaisal University?
The study plan for Master of Biomedical Science — Pharmacogenomics spans about 2 years (4 levels/semesters) under the approved plan.
What degree does Master of Biomedical Science — Pharmacogenomics award?
Master of Biomedical Science — Pharmacogenomics at Alfaisal University awards a Master's degree after completing 43 credit hours.